Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hennig

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Medicine|April 7, 2004
Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritisPeter Diehl, Bernd Hantke, Michael Hennig, et al.
German Medical Science : GMS E-Journal|February 7, 2017
Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa)Michael Hennig, Ferdinand Hundt, Susanne Busta, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 29, 2005
Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 A resolutionDaniel Schlatter, Ralf Thoma, Erich Küng, et al.
Biochemistry|December 14, 2005
Role of the N-terminal extension of the (betaalpha)8-barrel enzyme indole-3-glycerol phosphate synthase for its fold, stability, and catalytic activityBirgit Schneider, Thorsten Knöchel, Beatrice Darimont, et al.
Journal of Hypertension|April 7, 2007
Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on AtherosclerosisGiuseppe Mancia, Gianfranco Parati, Grzegorz Bilo, et al.
Journal of Hypertension|May 29, 2004
Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA)Alberto Zanchetti, M Gene Bond, Michael Hennig, et al.
Plos One|May 17, 2017
SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligandsSylwia Huber, Fabio Casagrande, Melanie N Hug, et al.
Journal of Molecular Biology|February 6, 2010
Structure of the human fatty acid synthase KS-MAT didomain as a framework for inhibitor designGünter Pappenberger, Jörg Benz, Bernard Gsell, et al.
Nature Reviews. Drug Discovery|August 13, 2016
Biophysics in drug discovery: impact, challenges and opportunitiesJean-Paul Renaud, Chun-Wa Chung, U Helena Danielson, et al.
FEBS Open Bio|June 18, 2013
Isothermal titration calorimetry with micelles: Thermodynamics of inhibitor binding to carnitine palmitoyltransferase 2 membrane proteinSamantha Perspicace, Arne C Rufer, Ralf Thoma, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Medicine|April 7, 2004
Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritisPeter Diehl, Bernd Hantke, Michael Hennig, et al.
German Medical Science : GMS E-Journal|February 7, 2017
Current practice and perspectives in CRO oversight based on a survey performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa)Michael Hennig, Ferdinand Hundt, Susanne Busta, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 29, 2005
Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 A resolutionDaniel Schlatter, Ralf Thoma, Erich Küng, et al.
Biochemistry|December 14, 2005
Role of the N-terminal extension of the (betaalpha)8-barrel enzyme indole-3-glycerol phosphate synthase for its fold, stability, and catalytic activityBirgit Schneider, Thorsten Knöchel, Beatrice Darimont, et al.
Journal of Hypertension|April 7, 2007
Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on AtherosclerosisGiuseppe Mancia, Gianfranco Parati, Grzegorz Bilo, et al.
Journal of Hypertension|May 29, 2004
Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA)Alberto Zanchetti, M Gene Bond, Michael Hennig, et al.
Plos One|May 17, 2017
SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligandsSylwia Huber, Fabio Casagrande, Melanie N Hug, et al.
Journal of Molecular Biology|February 6, 2010
Structure of the human fatty acid synthase KS-MAT didomain as a framework for inhibitor designGünter Pappenberger, Jörg Benz, Bernard Gsell, et al.
Nature Reviews. Drug Discovery|August 13, 2016
Biophysics in drug discovery: impact, challenges and opportunitiesJean-Paul Renaud, Chun-Wa Chung, U Helena Danielson, et al.
FEBS Open Bio|June 18, 2013
Isothermal titration calorimetry with micelles: Thermodynamics of inhibitor binding to carnitine palmitoyltransferase 2 membrane proteinSamantha Perspicace, Arne C Rufer, Ralf Thoma, et al.
Pageof 9